Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Equity

Summit Therapeutics (SMMT) Asset Utilization Ratio (2022 - 2025)

Summit Therapeutics' Asset Utilization Ratio history spans 4 years, with the latest figure at 0.01 for Q1 2025.

  • For Q1 2025, Asset Utilization Ratio rose 53.94% year-over-year to 0.01; the TTM value through Mar 2025 reached 0.01, up 53.94%, while the annual FY2022 figure was 0.0, 89.18% down from the prior year.
  • Asset Utilization Ratio reached 0.01 in Q1 2025 per SMMT's latest filing, up from 0.01 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.02 in Q3 2023 to a low of 0.02 in Q2 2024.
  • Average Asset Utilization Ratio over 4 years is 0.0, with a median of 0.0 recorded in 2022.
  • Peak YoY movement for Asset Utilization Ratio: surged 1071.03% in 2023, then crashed 254.22% in 2024.
  • A 4-year view of Asset Utilization Ratio shows it stood at 0.01 in 2022, then soared by 71.7% to 0.02 in 2023, then tumbled by 164.62% to 0.01 in 2024, then soared by 42.91% to 0.01 in 2025.
  • Per Business Quant, the three most recent readings for SMMT's Asset Utilization Ratio are 0.01 (Q1 2025), 0.01 (Q4 2024), and 0.01 (Q3 2024).